DrugPatentWatch Updates Drug Sales Information

June 16, 2011 - PRLog -- DrugPatentWatch.com is proud to announce the addition new drug sales information, profiling the top 2000 selling drugs based on last year's sales.

The addition of updated sales information complements existing indicators such as Paragraph IV challenges and patent claim types, providing a robust overview of the trends in pharmaceutical sales by branded and generic firms. This vital knowledge can aid investors in their decisions and help distributors and pharmacies plan their purchases.

Other datasets include:
- Impending drug patent expirations
- Annual sales
- Drug therapeutic class
- Paragraph IV challenges
- Premature patent expiration due to lack of maintenance fee payment
- Patent reexaminations
- Patent interferences
- Patent disclaimers
- Full-text drug patent PDFs
- Drug patent claim types (use, compound, formulation, etc.)

Detailed previews and a site tour are available at http://www.DrugPatentWatch.com

# # #

DrugPatentWatch provides comprehensive information on drug patents and their expirations.This value-added information supports patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.